Search results for 'drug manufacturing'

Yoga guru Ramdev summoned by SC in contempt case over Patanjali ads

Yoga guru Ramdev summoned by SC in contempt case over Patanjali ads

Rediff.com19 Mar 2024

The bench also issued notice to Ramdev to show cause why contempt proceedings be not initiated against him.

Cloud over US FDA inspection

Cloud over US FDA inspection

Rediff.com19 Jul 2008

Two US Congress members have expressed doubts over the quality of inspections conducted by the US Food and Drugs Administration (FDA) on Indian drug manufacturing facilities.

Eli Lilly plans alliances

Eli Lilly plans alliances

Rediff.com30 May 2007

The US-based drug maker Eli Lilly and Company will form strategic drug manufacturing and development alliances with major Indian pharmaceutical companies to tap the opportunities in contract research and manufacturing.

No patent on essential drugs: Govt

No patent on essential drugs: Govt

Rediff.com12 May 2006

Government on Friday assured the Rajya Sabha that essential drugs would not come under the new patent regime and companies manufacturing patented drugs would not be closed down.

Ranbaxy says its drugs are safe

Ranbaxy says its drugs are safe

Rediff.com14 Jun 2013

Ranbaxy Laboratories on Thursday said it will co-operate fully with any regulator from anywhere in the world wanting to investigate its manufacturing practices.

India probes four cough syrups after 66 Gambian children's deaths

India probes four cough syrups after 66 Gambian children's deaths

Rediff.com6 Oct 2022

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially be linked to the death of children in Gambia.

Govt in talks with SII for Nipah antibody, may put imports on hold

Govt in talks with SII for Nipah antibody, may put imports on hold

Rediff.com21 Sep 2023

Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies for treating Nipah virus infections and is in talks with Serum Institute of India, report Shine Jacob and Sohini Das.

USFDA nods Ranbaxy drug

USFDA nods Ranbaxy drug

Rediff.com23 Sep 2004

Ranbaxy Laboratories Ltd said on Thursday that it has bagged the US Food and Drug Administration's approval for manufacturing and marketing Loratadine and Pseudoephedrine Sulfate Extended-release tablets.

Ranbaxy to tie up with Merck

Ranbaxy to tie up with Merck

Rediff.com10 May 2008

India's leading drug maker Ranbaxy Laboratories is likely to announce a drug discovery research tie-up with US drug manufacturer Merck soon. Ranbaxy's ongoing research collaboration with GSK also relates to the pre-clinical trial phase of the new drug, with significant milestone payment and post-commercialisation royalty possibilities. Ranbaxy's decision to de-merge its research operations was intended at having more collaborative research programmes involving foreign firms.

SMS Pharmaceuticals: Bulk expansion

SMS Pharmaceuticals: Bulk expansion

Rediff.com6 Feb 2007

SMS Pharmaceuticals, a bulk drug manufacturer, is raising funds to augment capacity.

'Gave you my best': Biden passes the baton to Kamala

'Gave you my best': Biden passes the baton to Kamala

Rediff.com20 Aug 2024

Harris, 59, is scheduled to formally accept the Democratic Party's presidential nomination on Thursday to take on Republican rival Donald Trump, 78, in the November 5 election.

'Shortage of Tamiflu, masks won't be tolerated'

'Shortage of Tamiflu, masks won't be tolerated'

Rediff.com12 Aug 2009

The Union Health Ministry on Wednesday told the state governments to crack down on people hoarding and black-marketing swine flu drug Oseltamivir and masks used as protection against the disease, warning that their "shortage will not be tolerated."

Maharashtra drug body cracks down on misleading ads

Maharashtra drug body cracks down on misleading ads

Rediff.com7 May 2012

The Maharashtra Food and Drugs Administration has initiated action against manufacturers of medicines and instruments, newspapers, TV channels and cable operators making outrageous claims through advertisements.

Cancer, heart condition drugs to get cheaper following price cap

Cancer, heart condition drugs to get cheaper following price cap

Rediff.com24 Nov 2017

According to highly placed sources in NPPA, the reduction in prices following the latest exercise will range between six and 53 per cent.

Cipla to develop anti-allergy drug

Cipla to develop anti-allergy drug

Rediff.com12 Sep 2009

Domestic drug major Cipla Ltd has signed a long-term collaboration agreement with Swiss specialty pharmaceutical major Meda, to develop and market an anti-allergic rhinitis drug for various global markets. Cipla will manufacture the drug, which will treat an ailment that causes a runny nose, and the Swiss company will market the product in Europe, Japan, Brazil, South Korea and Australia. The partners are developing the product as a nasal spray to treat allergic rhinitis.

Which drugs will be costlier, cheaper now

Which drugs will be costlier, cheaper now

Rediff.com17 Mar 2011

The National Pharmaceutical Pricing Authority (NPPA) on Thursday said it has increased prices of 62 drugs, which are mainly based on indigenously manufactured insulin, giving a filip to domestic firms.

Uzbek cough syrup deaths: Govt to scrap Marion Biotech's licence

Uzbek cough syrup deaths: Govt to scrap Marion Biotech's licence

Rediff.com5 Mar 2023

The two directors of the company named in the FIR, however, still remain at large.

More R&D needs tax relief: Pharma cos tell govt

More R&D needs tax relief: Pharma cos tell govt

Rediff.com27 Jan 2010

The pre-Budget memoranda of the Indian Drug Manufacturers Association and the Federation of Indian Chambers of Commerce and Industry have said more incentives are needed to spur drug research.

Mexican drug lord 'El Chapo' found guilty; faces life in prison

Mexican drug lord 'El Chapo' found guilty; faces life in prison

Rediff.com13 Feb 2019

Joaquin "El Chapo" Guzman Loera was convicted on numerous counts including money laundering, engaging in a continuing criminal enterprise, distribution of heroin and cocaine and other drugs, and illegal arms possession.

WHO drops Cipla: HIV drug list

WHO drops Cipla: HIV drug list

Rediff.com16 Jun 2004

The World Health Organisation has excluded two generic antiretroviral drugs of Cipla from its list of approved HIV medicines used more often in poor countries.

Trump policies no threat, say Indian drug companies

Trump policies no threat, say Indian drug companies

Rediff.com13 Jan 2017

In his press conference on Wednesday, Trump targeted drug-makers and vowed to bring back production in the US.

Does India have enough vaccine reserves to combat another Covid wave?

Does India have enough vaccine reserves to combat another Covid wave?

Rediff.com27 Dec 2023

According to CoWIN data, only 73 vaccination centres are currently active in India, of which 32 are government-run.

Sunset for profitable drug window in US

Sunset for profitable drug window in US

Rediff.com22 Oct 2012

Sun Pharma could have to withdraw cancer drug as J&J re-enters after temporary eclipse

Ranbaxy gets Canada nod to market cholesterol drug

Ranbaxy gets Canada nod to market cholesterol drug

Rediff.com21 Jul 2009

The company's Canadian subsidiary Ranbaxy Pharmaceuticals -- Canada Inc has received final approval from TPD to manufacture and market Ran-Simvastatin tablets, the Gurgaon-headquartered pharma major said in a statement. The approval for Ran-Simvastatin tablets, which are used as a lipid metabolism regulator, is in the strength of 5, 10, 20, 40 and 80 mg.

Ranbaxy to sell Aussie firms cancer medicine

Ranbaxy to sell Aussie firms cancer medicine

Rediff.com26 Sep 2007

Sanjeev Dani, senior vice-president and regional director, Asia and CIS, Ranbaxy, said, "We are pleased to partner with Sirtex. We shall work towards creating a productive relationship."

Paswan promises to cut drug prices

Paswan promises to cut drug prices

Rediff.com21 Jun 2004

Union Minister for Chemicals and Fertilisers Ram Vilas Paswan said on Monday that his ministry would cut the prices of life saving and other important drugs by bringing more drugs under the 'price monitoring system' and also check the manufacture and

Cymbiotics, Elder Pharma sign 3 drug deal

Cymbiotics, Elder Pharma sign 3 drug deal

Rediff.com29 May 2007

Cymbiotics, a US-based bio-pharmaceutical manufacturer, has entered into a joint in-licensing agreement with Elder Pharmaceuticals to manufacture and market three of its drugs for pain management, diabetes and dermatology in the Indian market.

Are Indian drugs safe? US doctors worried over quality

Are Indian drugs safe? US doctors worried over quality

Rediff.com18 Mar 2014

Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

Ranbaxy recalls 29,790 packs of anti-allergy drug in US

Ranbaxy recalls 29,790 packs of anti-allergy drug in US

Rediff.com2 May 2014

Ranbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to defective packaging.

AyushMin gets rap for underuse of funds despite rising allocation

AyushMin gets rap for underuse of funds despite rising allocation

Rediff.com27 Feb 2024

Given the gap between budgetary allocation and use, a parliamentary standing committee has asked the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (Ayush) to take steps to prevent underutilisation of funds under the National Ayush Mission (NAM) scheme. According to the data, the ministry was allocated Rs 1,200 crore for the mission in the Budgetary Estimate (BE) for FY24. The Revised Estimate (RE) for the year fell to Rs 815 crore, of which Rs 589 crore, or 74 per cent, has been spent till January.

UP bans sale of halal-certified products, no restriction on exports

UP bans sale of halal-certified products, no restriction on exports

Rediff.com19 Nov 2023

In a statement, the state government alleged 'malicious attempts' to discourage the use of products lacking a halal certificate not only seek 'unfair financial benefits' but also form part of a 'pre-planned strategy to sow class hatred, create divisions in society, and weaken the country' by "anti-national elements".

Biocon drug gets nod for use in moderate to severe COVID-19 patients

Biocon drug gets nod for use in moderate to severe COVID-19 patients

Rediff.com11 Jul 2020

DCGI has approved to market Itolizumab (ALZUMAb) injection 25mg and 5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19, Biocon said in a release.

India keen on pharma exports to China

India keen on pharma exports to China

Rediff.com16 Mar 2011

China's API exports to India touched $3.3 billion last year, while Indian drugs struggled to post $500 million worth of exports to China.

Flu drug plans take a hit

Flu drug plans take a hit

Rediff.com17 Nov 2005

Glaxo interested in Indian acquisitions

Glaxo interested in Indian acquisitions

Rediff.com9 Mar 2010

GlaxoSmithKline, the world's second biggest drug maker, said it was interested in acquisitions in India if the assets came at the right value.

Govt to withdraw UPA drug regulatory bill, draft new rules

Govt to withdraw UPA drug regulatory bill, draft new rules

Rediff.com22 Jun 2016

India is one of the largest manufacturers of pharmaceutical products in the world with the annual production valued at over Rs 2 lakh crore.

Substandard drugs: SC's clean chit to Ranbaxy

Substandard drugs: SC's clean chit to Ranbaxy

Rediff.com25 Jun 2013

The petitioner failed to bring in evidence against Ranbaxy, said Supreme Court.

Pharma firms agree on VAT

Pharma firms agree on VAT

Rediff.com3 Jun 2005

WHO works on cheaper R&D for India

WHO works on cheaper R&D for India

Rediff.com24 Sep 2007

The R&D plan, focused on diseases affecting poor nations, is expected to be ready by 2008 and may benefit Indian drug firms and contract research organisations in a big way.

Hand over central lab report to J&J: HC tells Maha

Hand over central lab report to J&J: HC tells Maha

Rediff.com27 Oct 2022

A vacation bench of Justices NJ Jamadar and Sharmila Deshmukh passed the decision on Wednesday while hearing a petition filed by the company challenging two orders of the state government.